Pontus Berganäs
Associate, Stockholm
Corporate Advisory, Equity Capital Markets, Public M&A
Contact
Pontus Kittel Berganäs is a Stockholm-based Associate working with Roschier’s Corporate Advisory, Equity Capital Markets and Public M&A practices. Pontus joined Roschier in 2021.
Work highlights
Pontus Kittel Berganäs’s experience includes advising:
- Frazier Life Sciences in its additional USD 10 million investment in Egetis Therapeutics;
- CVC in the SEK 1.1 billion sell-down of shares in Synsam;
- TA Associates in the fully underwritten SEK 4.3 billion rights issue in Elos Medtech;
- Cargill in an offtake agreement and the commitment to invest in Nordic Iron Ore;
- Navamedic in the recommended cash offer to acquire Sensidose;
- Vinted in the SEK 315 million public offer for all shares in Rebelle;
- Aareon AG in its acquisition and delisting of Momentum Software Group
- Braathens Regional Airlines in connection with AMF’s SEK 200 million investment;
- TA Associates in connection with the public tender offer for Elos Medtech.
Career
Roschier (2021-)
Education
Uppsala University, LL.M., (2021)
Languages
English, Swedish